NCT00077753 - EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization | Biotech Hunter

Enrollment

4,726

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2006

Study Completion Date

February 28, 2007

Conditions

Venous Thromboembolism

Interventions

DRUG

enoxaparin sodium

Trial Locations (20)

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Buenos Aires

Sanofi-Aventis, North Ryde

Sanofi-Aventis, Vienna

Sanofi-Aventis, Brussels

Sanofi-Aventis, São Paulo

Sanofi-Aventis, Laval

Sanofi-Aventis, Bogotá

Sanofi-Aventis, Paris

Sanofi-Aventis, Berlin

Sanofi-Aventis, Mumbai

Sanofi-Aventis, Netanya

Sanofi-Aventis, Milan

Sanofi-Aventis, México

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Moscow

Sanofi-Aventis, Johannesburg

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Mégrine

Sanofi-Aventis, Guildford